Sign in to continue:

Wednesday, March 11th, 2026

Kohl’s Reports Fiscal 2025 Results: Sales Decline but Earnings and Cash Flow Improve, Introduces 2026 Outlook





Kohl’s Reports Q4 and Full Year 2025 Results: Key Insights for Investors

Kohl’s Reports Q4 and Full Year 2025 Results: Key Insights for Investors

Summary of Financial Performance

  • Q4 Net Sales: Decreased 3.9% year-over-year to \$5.0 billion; comparable sales decreased 2.8%.
  • Full Year Net Sales: Decreased 4.0% to \$14.8 billion; comparable sales down 3.1%.
  • Q4 Earnings: Diluted EPS of \$1.07, up from \$0.43 in the prior year.
  • Full Year Earnings: Diluted EPS of \$2.38; adjusted diluted EPS of \$1.62.
  • Gross Margin: Q4 gross margin increased to 33.1% (up 25 bps); full year gross margin rose to 37.5% (up 34 bps).
  • SG&A Expenses: Decreased 4.9% in Q4 and 4.1% for the year, reflecting expense discipline.
  • Operating Income: Q4: \$212 million (up from \$126 million); FY: \$624 million (up from \$433 million).
  • Net Income: Q4: \$125 million (up from \$48 million); FY: \$272 million (up from \$109 million).
  • Operating Cash Flow: Q4: \$750 million (up from \$596 million); FY: \$1.4 billion (up from \$648 million).
  • Inventory: \$2.7 billion, down 7% year-over-year.
  • Debt Reduction: No borrowings under revolving credit facility (down \$290 million); repaid \$353 million in long-term debt due July 2025.
  • Long-Term Debt: Increased \$262 million due to new issuance of \$360 million 10% senior secured notes due 2030, partially offset by \$87 million in debt repurchases.
  • Legal Settlement: \$129 million gain from credit card interchange fee lawsuit settlement.

Management Commentary

CEO Michael J. Bender stated that Kohl’s ended 2025 in a stronger position than it began, despite a softer Q4 topline. Management focused on resetting the foundation, stabilizing the business, and strengthening operational ability. The company delivered improved earnings and stronger cash flow, helping to strengthen its balance sheet.

For 2026, Kohl’s is committed to further strengthening its foundation, addressing operational opportunities, building on strengths, and modernizing processes to benefit long-term performance.

2026 Financial Outlook

  • Net Sales & Comparable Sales: Expected to decrease (2%) to flat.
  • Adjusted Operating Margin: Anticipated in the range of 2.8% to 3.4%.
  • Adjusted Diluted EPS: Projected range of \$1.00 to \$1.60.
  • Capital Expenditures: Expected at \$350 to \$400 million.
  • Dividend: Quarterly cash dividend of \$0.125 per share declared, payable April 1, 2026 to shareholders of record as of March 18, 2026.

Balance Sheet Highlights

  • Cash & Cash Equivalents: \$674 million as of January 31, 2026 (up from \$134 million).
  • Total Assets: \$13.36 billion, relatively flat year-over-year.
  • Shareholders’ Equity: Rose to \$4.05 billion from \$3.80 billion.
  • Total Current Liabilities: \$2.53 billion (down from \$3.13 billion).

Cash Flow Details

  • Operating Activities: Net cash provided of \$1.38 billion (more than double prior year).
  • Investing Activities: Net cash used of \$333 million (mainly for property and equipment acquisitions).
  • Financing Activities: Net cash used of \$507 million, including new debt issuance, debt repayment, and dividend payments.

Key Price-Sensitive Items for Shareholders

  • Profitability Improvements: Significant increases in operating and net income, along with improved gross margin, may positively influence investor sentiment and share price.
  • Cash Flow Strength: The doubling of operating cash flow to \$1.4 billion provides more financial flexibility and strengthens Kohl’s balance sheet.
  • Debt Management: Reduction in revolving credit borrowings and repayment of long-term debt, alongside the new debt issuance at a higher interest rate (10% notes), could have mixed implications for credit outlook and interest expense.
  • Dividend Policy: The continuation of dividends at \$0.125 per share per quarter signals ongoing commitment to shareholder returns.
  • Legal Settlement Windfall: The one-time \$129 million gain from a credit card interchange fee lawsuit settlement contributed to the year’s net income but should be considered non-recurring.
  • 2026 Guidance: The outlook for flat to slightly negative sales growth and lower EPS guidance (\$1.00-\$1.60 vs. \$1.62 in 2025) suggests management expects continued operational headwinds and a challenging retail environment in the near term.
  • Non-GAAP Adjustments: Investors should be aware of the impact of non-GAAP adjustments on reported profitability and comparability to peers.

Additional Operational and Strategic Notes

  • Inventory Management: Inventory reduction by 7% year-over-year could help limit markdown risks and improve cash conversion.
  • Expense Discipline: Ongoing SG&A cost reductions are supporting margin improvements, but future cost controls will be critical as top-line growth remains pressured.
  • Capital Allocation: Planned capital expenditures of \$350–\$400 million in 2026 suggest continued investment in store operations, digital, and modernization.

Conclusion

Kohl’s delivered stronger earnings and cash flow in fiscal 2025, despite declining sales, through disciplined expense management and margin improvement. The company enters 2026 with a stronger balance sheet but expects continued sales pressures and lower profits, indicating strategic caution amid a challenging retail landscape. Investors should monitor the company’s execution on operational improvements and sales stabilization, as well as its management of debt and capital allocation.

These results, outlook, and capital allocation decisions are material and could influence Kohl’s share price in the upcoming quarters.


Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Financial data are based on public filings as of January 31, 2026. Investors should perform their own due diligence and consult a financial advisor before making investment decisions. Past performance is not indicative of future results.




View KOHLS Corp Historical chart here



Supernus Pharmaceuticals 2025 Annual Report: CNS Drug Portfolio, Pipeline, IP, and Market Overview

Supernus Pharmaceuticals, Inc. 2025 Annual Report: Key Highl...

Newbury Street II Acquisition Corp 2025 Annual Report: Business Strategy, Management, and SPAC Overview

Newbury Street II Acquisition Corp Annual Report: Key Highli...

Archer Aviation 2025 Annual Report: Business Overview, Risk Factors, and Strategic Plans

Archer Aviation Inc. 2025 Annual Report: Key Highlights for ...

   Ad